B2B Consumable Strategy | Yesiwell Product & Sales Team | May 2026 | 9 min read
Walk into most pharmacies or medical supply catalogues and you will find blood glucose meters prominently displayed, test strips stocked in multiple sizes, and lancets — when they appear at all — tucked into a corner in one or two generic options. That shelf arrangement tells you something about how the category is being managed. It also tells you exactly where a significant and recurring revenue stream is being left for someone else to pick up.
The arithmetic is not complicated. A patient monitoring their blood glucose twice a day uses approximately 730 lancets per year — one per test, assuming they replace the lancet every time as recommended. A patient testing four times a day uses close to 1,500. At a retail price of even $0.10 per lancet — which is on the low end of market pricing — that is $73 to $150 in annual lancet spending per patient, per year, indefinitely.
Most distributors who stock glucose meters also stock test strips, because the strip consumable model is well understood: the meter opens the relationship, the strips sustain it. Lancets work on the same logic — but most distributors either carry only one generic option or do not carry lancets at all, leaving their customers to buy from a pharmacy shelf or online retailer that has no connection to the original meter purchase.
The reason this happens is partly historical. Lancets were long treated as a commodity — a low-differentiation product where the only competition was price. That was never entirely true, and it is less true now than it has ever been. Gauge size, needle coating, tip geometry, lancing device compatibility, and sterility packaging all vary meaningfully across lancet products, and patients who find one they like tend to reorder it consistently. Brand loyalty in lancets, once established, is stronger than in almost any other diabetes consumable category.
Before building a lancet range, it helps to understand what actually separates products in this category — because the differences that matter to patients are not the ones most visible on generic wholesale listings.
Lancet gauge refers to the thickness of the needle. The gauge scale runs counter-intuitively: higher gauge numbers mean thinner needles. A 33G lancet has a narrower needle than a 28G lancet, and produces less pain and a smaller wound per test.
The trade-off is that thinner needles produce smaller blood droplets, which can be insufficient for patients with thicker or calloused skin — common in older patients and those who have been testing for years. Most patients who test regularly and have no skin issues prefer 30G to 33G. Patients with particularly thin, sensitive skin — or children — often benefit from the finest available gauge. A well-structured lancet range covers at minimum 28G, 30G, and 33G, giving pharmacy staff and patients the ability to match gauge to skin type.
This is the specification most generic lancet listings do not mention, and it is the one patients notice most directly in how the lancet feels. Better-quality lancets use a bevelled, three-facet tip geometry that cuts cleanly through skin with less tearing. Low-quality lancets often have simpler tip geometry that causes more trauma per test — which patients describe as the lancet "dragging" rather than puncturing.
Silicone coating on the needle reduces friction further. A coated, fine-geometry lancet from a quality manufacturer versus an uncoated basic lancet at the same gauge can feel categorically different to the patient — even if the specifications on the box look similar. This is a tangible product quality difference that creates real preference, which means it creates real reorder loyalty when you stock the better product.
Lancets are used with a lancing device — a spring-loaded pen that holds the lancet and controls puncture depth. Most lancing devices accept universal-fit lancets in the common gauge sizes. However, some devices use proprietary lancet formats, and patients who own those devices are locked into sourcing compatible lancets. Before building your lancet SKU range, confirm whether your target customers predominantly use universal-fit devices or proprietary systems, and stock accordingly.
If you are supplying a bundled blood glucose monitoring kit that includes a lancing device, selecting a compatible branded lancet to accompany it creates a complete consumable ecosystem that patients reorder through you — rather than through whichever pharmacy shelf has the cheapest generic box that week.
Patient buys meter and strips from you — then buys lancets elsewhere
Generic lancet purchase creates no brand loyalty to your distribution network
Each reorder is a new decision — another opportunity for a competitor to capture the customer
No data on patient usage patterns — you cannot forecast lancet demand or plan strip reorders
One-SKU approach means patients with skin-type or gauge preferences go elsewhere
Patient buys meter, strips, and lancets from the same source — you
Gauge preference creates consistent, predictable reorder behaviour
Bundled or recommended lancet at point of meter sale converts the first reorder immediately
Private-label lancets deepen brand ownership across the full testing routine
Lancet reorder data provides early signal of patient compliance and strip demand
The shift from a one-SKU lancet offering to a structured two- or three-SKU range — covering different gauges and potentially a lancing device — does not require significant investment in new supplier relationships. If your current glucose meter supplier also manufactures lancets, consolidating supply simplifies procurement, reduces minimum order complexity, and often improves unit pricing through combined volume.
Clinical guidelines recommend using a fresh lancet for every single test. The reality is that many patients reuse lancets across multiple tests — sometimes for an entire day, sometimes longer. This is not a hygiene lecture opportunity; it is relevant commercial information. It means that actual lancet consumption per patient per month is lower than the theoretical maximum, and unit volume projections based on single-use compliance will be overstated.
More importantly, it means that patients who are most diligent about proper testing technique — single-use lancets, correct finger rotation, appropriate gauge for their skin — are also the patients most likely to follow structured fasting and post-meal monitoring routines. These are your highest-value customers from a consumable perspective: they test frequently, they do it correctly, and they reorder consistently. A lancet range that serves them well — with fine gauge options, quality tip geometry, and consistent availability — retains that customer more effectively than any pricing promotion.
Lancet quality directly affects blood sample quality — which affects reading accuracy. A dull or reused lancet increases the likelihood of patients squeezing the puncture site too hard to get enough blood, introducing interstitial fluid into the sample and skewing the result downward. This is one of the seven common testing mistakes that lead to inaccurate readings — and it starts with lancet choice, not meter choice.
The most effective lancet strategy for a distributor already selling blood glucose meters is not to build a standalone lancet category — it is to integrate lancets structurally into the meter purchase decision. Three approaches work consistently:
Bundle a starter pack at the point of meter sale. A box of 100 lancets included with or offered alongside each meter purchase converts the first consumable reorder immediately. The patient now has a preference established — your lancet — before they have ever bought lancets independently. This is the lowest-effort, highest-conversion integration available.
Recommend by gauge at the point of sale. Training pharmacy staff or distributor sales teams to ask one question — "Does the patient prefer a finer or standard gauge?" — and stock accordingly turns lancets from a passive shelf item into an active recommendation. Patients who receive a gauge recommendation based on their skin type reorder that specific product far more reliably than those who picked the cheapest box available.
Private-label lancets under your brand or Yesiwell's OEM program. Branded lancets carry the same brand as the meter and strips, reinforcing the complete system identity. A patient who sees the same brand name on their meter, their strip vial, and their lancet box is significantly less likely to substitute any component with a third-party product. This is the highest-investment approach but produces the strongest long-term retention — particularly relevant for distributors building a private-label diabetes care ecosystem.
Lancet demand is not uniform across markets, and understanding the variation helps with range planning and volume forecasting.
In Western Europe, single-use compliance is higher than in most other regions — partly due to stronger patient education infrastructure, partly due to the fact that lancets are often reimbursed alongside strips through national health schemes, which reduces the cost-driven incentive to reuse. This means actual consumption per patient tracks closer to the theoretical single-use maximum. Germany and France in particular have established reimbursement pathways for lancets in Type 1 and insulin-dependent Type 2 patients.
In the GCC and Middle East, lancet availability has historically been patchy — dominated by a small number of multinational brands at premium price points, with limited mid-tier options. This represents a genuine supply gap that a well-priced, CE-certified lancet range can enter with minimal direct competition in many sub-markets. Gauge preference in the region tends toward 28G and 30G, as the patient population skews older and often has more robust skin from manual work or sun exposure.
In Southeast Asia, price is the primary driver, and private-label or OEM lancets at accessible price points have significant distribution potential through pharmacy chains and clinic supply contracts. The market is less sensitive to fine gauge differentiation than Western Europe, making a simpler two-SKU range (28G and 30G) more appropriate as an entry point.
“We never thought much about lancets — they felt like a commodity. Then we ran the numbers on what our glucose meter customers were buying from competitors and realised we were missing roughly 30% of the consumable revenue attached to every meter we sold. Adding a two-gauge lancet SKU under our private label took three months. It was the highest-margin addition we made that year.”
— Regional medical device distributor, Middle East, Yesiwell partner
Yesiwell supplies CE-certified lancets in multiple gauge sizes, available for wholesale distribution or OEM private-label programs alongside our blood glucose monitor and test strip range. Whether you are building a bundled starter kit, adding a gauge-structured lancet range to an existing portfolio, or developing a fully branded diabetes consumable ecosystem, our team can advise on SKU configuration, MOQ options, and regulatory documentation for your target markets.
Most distributors who start this conversation are surprised by how quickly a lancet program pays back. The margin is there — it just needs to be claimed.
Your fasting reading and your two-hour post-meal reading measure different things. Understanding the difference changes what you do with the information and when you actually need to test.
Connected glucose meters carry a higher price and more complex support requirements. Yesiwell's B2B guide helps distributors decide when the smart category is worth adding.
READ MOREIf you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.
